| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.06 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.06 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.06 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.055 | 0.07 |